Adopted Trials - bowel (colon)
Acronym: BOXER
Full Title
Phase II multicentre clinical trial of capecitabine and oxaliplatin plus bevacizumab as neoadjuvant treatment for patients with previously untreated unresectable liver-only metastases from colorectal cancer
Treatment: chemotherapy
Phase: II
Chief Investigator: Professor David Cunningham
Type of trial: Early Phase
Website:
Acronym: FUTURE (COMMERCIAL)
Full Title
A randomised open label phase II study evaluating the efficacy and safety of FOLFOX-4 plus cetuximab versus UFOX plus cetuximab as first-line therapy in subjects with metastatic colorectal cancer
Treatment: chemotherapy
Phase: II
Chief Investigator: Prof J-Y Douillard
Type of trial: Early Phase
Website:
